The use of 2-chloroprocaine for spinal anaesthesia

Acta Anaesthesiologica Scandinavica

Volumn 57, Issue 5, 2013, Pages 545-552

  Goldblum, E ^a   Atchabahian, A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ARTICAINE; ATROPINE; BUPIVACAINE; CHLOROPROCAINE; CLONIDINE; FENTANYL; HYPERTENSIVE FACTOR; LIDOCAINE; PROCAINE;

BRADYCARDIA; CAUDA EQUINA SYNDROME; EMBASE; HISTORY; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; KNEE ARTHROSCOPY; LOCAL ANESTHESIA; MEDLINE; MOBILIZATION; NEUROTOXICITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SPINAL ANESTHESIA; TRANSURETHRAL RESECTION;

ANESTHESIA, SPINAL; ANESTHETICS, LOCAL; HUMANS; PROCAINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84876290928     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/aas.12071     Document Type: Review

References (39)

1. Schneider M, Ettlin T, Kauffmann M, Schumacher P, Urwyler A, Hampl K, von Hochstetter A. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154-7.
2. Tarkkila P, Huhtala J, Tuominen M. Transient radicular irritation after spinal anaesthesia with hyperbaric 5% ligno-caine. Br J Anaesth 1995; 74: 328-9.
3. Pollock JE, Mulroy MF, Bent E, Polissar NL. A comparison of two regional anesthetic techniques for outpatient knee arthroscopy. Anesth Analg 2003; 97: 397-401.
4. Freedman JM, Li DK, Drasner K, Jaskela MC, Larsen B, Wi S. Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1, 863 patients. Anesthesiology 1998; 89: 633-41.
5. Hampl KF, Schneider MC, Pargger H, Gut J, Drewe J, Drasner K. A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine. Anesth Analg 1996; 83: 1051-4.
6. Hiller A, Rosenberg PH. Transient neurological symptoms after spinal anesthesia with 4% mepivacaine and 0.5% bupi-vacaine. Br J Anaesth 1997; 79: 301-5.
7. YaDeau JT, Liguori GA, Zayas VM. The incidence of transient neurologic symptoms after spinal anesthesia with mepivacaine. Anesth Analg 2005; 101: 661-5.
8. Liu SS, Ware PD, Allen HW, Neal JM, Pollock JE. Dose-response characteristics of spinal bupivacaine in volunteers. Clinical implications for ambulatory anesthesia. Anesthesi-ology 1996; 85: 729-36.
9. Hodgson PS, Liu SS, Batra MS, Gras TW, Pollock JE, Neal JM. Procaine compared with lidocaine for incidence of transient neurologic symptoms. RegAnesth Pain Med 2000; 25: 218-22.
10. Snoeck M. Articaine: a review of its use for local and regional anesthesia. Local Reg Anesth 2012; 5: 23-33.
11. Fu RQ, Tian YK, Fang WR. Combined spinal and epidural anaesthesia with chloroprocaine for hysterectomy. Clin Exp Pharmacol Physiol 2008; 35: 60-3.
12. Foldes FF, Mc Nall PG. 2-chloroprocaine: a new local anesthetic agent. Anesthesiology 1952; 13: 287-96.
13. Reisner LS, Hockman BN, Plumer MH. Persistent neurologic deficit and adhesive arachnoiditis following intrathecal 2-chloroprocaine injection. Anesth Analg 1980; 59: 452-4.
14. Ravindran RS, Bond VK, Tasch MD, Gupta CD, Luerssen TG. Prolonged neural blockade following regional anesthesia with 2-chloroprocaine. Anesth Analg 1980; 59: 447-51.
15. Moore DC, Spierdijk J, vanKleef JD, Coleman RL, Love GF. Chloroprocaine neurotoxicity: four additional cases. Anesth Analg 1982; 61: 158-9.
16. Gissen AJ, Datta S, Lambert D. The chloroprocaine controversy. II. Is chloroprocaine neurotoxic? Reg Anesth 1984; 9: 135-44.
17. Gissen A. Toxicity of local anesthetics in obstetrics. II. Chlo-roprocaine: research and clinical aspects. Clin Anesthesiol 1986; 4: 101-8.
18. Wang BC, Hillman DE, Spielholz NI, Turndorf H. Chronic neurological deficits and Nesacaine-CE-an effect of the anesthetic, 2-chloroprocaine, or the antioxidant, sodium bisulfite? Anesth Analg 1984; 63: 445-7.
19. Wang BC, Li D, Hiller JM, Simon EJ, Budzilovich G, Hillman DE. Lumbar subarachnoid ethylenediaminetetraacetate induces hindlimb tetanic contractions in rats: prevention by CaCl2 pretreatment; observation of spinal nerve root degeneration. Anesth Analg 1992; 75: 895-9.
20. Taniguchi M, Bollen AW, Drasner K. Sodium bisulfate: scapegoat for chloroprocaine toxicity? Anesthesiology 2004; 100: 85-91.
21. Drasner K. Chloroprocaine spinal anesthesia: back to the future? Anesth Analg 2005; 100: 549-52.
22. Cabre F, Marin C, Cascante M, Canela EI. Occurrence and comparison of sulfite oxidase activity in mammalian tissues. Biochem Med Metab Biol 1990; 43: 159-62.
23. Na KB, Kopacz DJ. Spinal chloroprocaine solutions: density at 37 °C and pH titration. Anesth Analg 2004; 98: 70-4.
24. Smith KN, Kopacz DJ, McDonald SB. Spinal 2-chloroprocaine: a dose-ranging study and the effect of added epinephrine. Anesth Analg 2004; 98: 81-8.
25. Kouri ME, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with lidocaine in volunteers. Anesth Analg 2004; 98: 75-80.
26. Warren DT, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added dextrose. Anesth Analg 2004; 98: 95-101.
27. Davis BR, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added clonidine. Anesth Analg 2005; 100: 559-65.
28. Vath JS, Kopacz DJ. Spinal 2-chloroprocaine: the effect of added fentanyl. Anesth Analg 2004; 98: 89-94.
29. Gonter AF, Kopacz DJ. Spinal 2-chloroprocaine: a comparison with procaine in volunteers. Anesth Analg 2005; 100: 573-9.
30. Kopacz DJ. Spinal 2-chloroprocaine: minimum effective dose. Reg Anesth Pain Med 2005; 30: 36-42.
31. Casati A, Danelli G, Berti M, Fioro A, Fanelli A, Benassi C, Petronella G, Fanelli G. Intrathecal 2-chloroprocaine for lower-limb outpatient surgery: a prospective, randomized, double-blind, clinical evaluation. Anesth Analg 2006; 103: 234-8.
32. Lacasse MA, Roy JD, Forget J, Vandenbroucke F, Seal RF, Beaulieu D, McCormack M, Massicotte L. Comparison of bupivacaine and 2-chloroprocaine for spinal anesthesia for outpatient surgery: a double-blind randomized trial. Can J Anaesth 2011; 58: 384-91.
33. Förster JG, Kallio H, Rosenberg PH, Harilainen A, Sandelin J, Pitkänen MT. Chloroprocaine vs. articaine as spinal anaesthetics for day-case knee arthroscopy. Acta Anaesthe-siol Scand 2011; 55: 273-81.
34. Vaghadia H, Neilson G, Lennox PH. Selective spinal anesthesia for outpatient transurethral prostatectomy (TURP): randomized controlled comparison of chloropro-caine with lidocaine. Acta Anaesthesiol Scand 2012; 56: 217-23.
35. Casati A, Fanelli G, Danelli G, Berti M, Ghisi D, Brivio M, Putzu M, Barbagallo A. Spinal anesthesia with lidocaine or preservative-free 2-chlorprocaine for outpatient knee arthroscopy: a prospective, randomized, double-blind comparison. Anesth Analg 2007; 104: 959-64.
36. Yoos JR, Kopacz DJ. Spinal 2-chloroprocaine for surgery: an initial 10-month experience. Anesth Analg 2005; 100: 553-8.
37. Hejtmanek MR, Pollock JE. Chloroprocaine for spinal anesthesia: a retrospective analysis. Acta Anaesthesiol Scand 2011; 55: 267-72.
38. Tseng S, Pak G, Washenik K, Pomeranz MK, Shupack JL. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 1996; 35: 969-79.
39. Bloomfield R, Noble DW. Etomidate, pharmacological adrenalectomy and the critically ill: a matter of vital importance. Crit Care 2006; 10: 161-2.